Citadel Advisors
NARI

Citadel Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Citadel Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,500
Closed -$230K – 15965
2024
Q4 		$230K Buy
4,500
+200
+5% +$9.83K ﹤0.01% 10195
2024
Q3 		$177K Sell
4,300
-600
-12% -$28.8K ﹤0.01% 10323
2024
Q2 		$236K Sell
4,900
-18,600
-79% -$824K ﹤0.01% 9591
2024
Q1 		$1.13M Buy
23,500
+15,400
+190% +$823K ﹤0.01% 6681
2023
Q4 		$526K Sell
8,100
-16,800
-67% -$1.01M ﹤0.01% 7985
2023
Q3 		$1.63M Sell
24,900
-1,200
-5% -$75.5K ﹤0.01% 5588
2023
Q2 		$1.52M Sell
26,100
-30,700
-54% -$1.94M ﹤0.01% 5659
2023
Q1 		$3.51M Buy
56,800
+46,100
+431% +$2.77M ﹤0.01% 4389
2022
Q4 		$680K Buy
10,700
+300
+3% +$21.8K ﹤0.01% 7603
2022
Q3 		$755K Sell
10,400
-900
-8% -$67K ﹤0.01% 7602
2022
Q2 		$768K Sell
11,300
-43,100
-79% -$3.1M ﹤0.01% 7633
2022
Q1 		$4.93M Buy
54,400
+43,800
+413% +$3.59M ﹤0.01% 4199
2021
Q4 		$967K Sell
10,600
-13,900
-57% -$1.19M ﹤0.01% 8052
2021
Q3 		$1.99M Sell
24,500
-3,500
-13% -$294K ﹤0.01% 6354
2021
Q2 		$2.61M Sell
28,000
-23,100
-45% -$2.24M ﹤0.01% 5928
2021
Q1 		$5.47M Buy
51,100
+24,300
+91% +$2.52M ﹤0.01% 4061
2020
Q4 		$2.34M Buy
26,800
+20,900
+354% +$1.48M ﹤0.01% 5031
2020
Q3 		$407K Buy
+5,900
New +$379K ﹤0.01% 7635

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Citadel Advisors's NARI Position: Q1 2025 in Review

Citadel Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 231,696 shares — an estimated $11.8M sold.

Citadel Advisors first reported a position in NARI in Q3 2020 and held it in 14 quarters. The position peaked at $92.3M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Citadel Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 231,696 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $11.8M.
  • Citadel Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Citadel Advisors's Inari Medical, Inc. Common Stock position peaked at $92.3M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.